At a glance
- Originator Pfizer
- Class Acrylates; Anti-ischaemics; Neuroprotectants
- Mechanism of Action Calpain inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 21 Feb 2000 No-Development-Reported for Neurological disorders (Prevention) in USA (Unknown route)
- 26 Mar 1997 New profile
- 26 Mar 1997 Preclinical development for Neurological disorders (Prevention) in USA (Unknown route)